Colorectal cancer after a negative Haemoccult II® test and programme sensitivity after a first round of screening: the experience of the Department of Calvados (France)
1999
Colorectal Cancer After Negative Haemoccult II Test
publication
Author Information
Author(s): Bouvier V, Launoy G, Herbert C, Lefevre H, Maurel J, Gignoux M
Primary Institution: Registre des Tumeurs Digestives du Calvados, CJF INSERM
Hypothesis
What is the incidence of colorectal cancer after a negative Haemoccult II test in a mass screening program?
Conclusion
The incidence of colorectal cancer after a negative test was lower than in the reference group, and the program's sensitivity was higher than in European trials.
Supporting Evidence
- The incidence of cancer after a negative test was 57.7 per 100,000.
- This incidence is half of that in the reference group, which was 141.6 per 100,000.
- The program's sensitivity was estimated to be higher than in European trials.
Takeaway
This study looked at how many people got colorectal cancer after a negative test result, finding that fewer people got cancer than expected.
Methodology
The study identified cancer cases after negative tests using a local cancer registry and calculated incidence and program sensitivity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website